 |
Amphastar Pharmaceuticals
AMPH
|
70.9 |
$ 19.68 |
0.92 % |
$ 920 M |
USA |
 |
Amarin Corporation plc
AMRN
|
213 |
$ 14.5 |
0.03 % |
$ 6.02 B |
Irlanda |
 |
GlaxoSmithKline plc
GSK
|
0.0222 |
$ 52.37 |
1.02 % |
$ 173 B |
Britain |
 |
I-Mab
IMAB
|
271 |
- |
- |
$ 866 M |
China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
84.7 |
- |
- |
$ 40.3 B |
USA |
 |
Ascendis Pharma A/S
ASND
|
132 |
$ 221.59 |
-0.13 % |
$ 5 B |
Danmark |
 |
Midatech Pharma plc
MTP
|
204 |
- |
-18.52 % |
$ 27.3 M |
Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.75 K |
- |
-1.52 % |
$ 24.7 M |
USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
0.114 |
- |
- |
$ 26.5 M |
USA |
 |
Aeterna Zentaris
AEZS
|
146 |
- |
5.93 % |
$ 314 M |
Canada |
 |
AgeX Therapeutics
AGE
|
78.4 |
- |
-10.17 % |
$ 12.2 K |
USA |
 |
Acorda Therapeutics
ACOR
|
48.3 |
- |
-24.86 % |
$ 820 K |
USA |
 |
Albireo Pharma
ALBO
|
14.7 |
- |
-0.23 % |
$ 916 M |
USA |
 |
Acasti Pharma
ACST
|
1.97 |
- |
4.01 % |
$ 150 M |
Canada |
 |
Heron Therapeutics
HRTX
|
198 |
$ 0.81 |
3.74 % |
$ 135 M |
USA |
 |
Adverum Biotechnologies
ADVM
|
222 |
- |
- |
$ 86.2 M |
USA |
 |
Advaxis
ADXS
|
88.1 |
- |
-9.65 % |
$ 45.9 M |
USA |
 |
Ayala Pharmaceuticals
AYLA
|
61.7 |
- |
- |
$ 7.46 M |
Israel |
 |
Benitec Biopharma
BNTC
|
141 |
$ 11.05 |
0.64 % |
$ 455 M |
USA |
 |
BioDelivery Sciences International
BDSI
|
115 |
- |
-4.8 % |
$ 255 M |
USA |
 |
BeiGene, Ltd.
BGNE
|
52.6 |
- |
0.49 % |
$ 251 B |
Cayman-islands |
 |
Calithera Biosciences
CALA
|
28.8 |
- |
-10.95 % |
$ 876 K |
USA |
 |
Cara Therapeutics
CARA
|
52.4 |
- |
-3.03 % |
$ 260 M |
USA |
 |
ChemoCentryx
CCXI
|
3.1 |
- |
- |
$ 3.74 B |
USA |
 |
Incyte Corporation
INCY
|
66.6 |
$ 90.36 |
-0.47 % |
$ 17.6 B |
USA |
 |
InMed Pharmaceuticals
INM
|
3.83 |
$ 0.74 |
-9.75 % |
$ 1.81 M |
Canada |
 |
INmune Bio
INMB
|
60.1 K |
$ 1.17 |
-0.43 % |
$ 21 M |
USA |
 |
Checkpoint Therapeutics
CKPT
|
6.83 |
- |
- |
$ 169 M |
USA |
 |
Clovis Oncology
CLVS
|
65.5 |
- |
-7.23 % |
$ 13 M |
USA |
 |
Aeglea BioTherapeutics
AGLE
|
216 |
- |
- |
$ 1.01 B |
USA |
 |
CureVac N.V.
CVAC
|
13.6 |
- |
- |
$ 867 M |
Germany |
 |
Compugen Ltd.
CGEN
|
60.8 |
$ 2.13 |
1.91 % |
$ 199 M |
Israel |
 |
Arbutus Biopharma Corporation
ABUS
|
31.5 |
$ 4.43 |
4.6 % |
$ 735 M |
Canada |